Intelligence · Drug directory

Withdrawn Drug Applications

Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.

Quick answer

Withdrawn applications: NovaPharmaNews tracks 229 pharmaceutical drugs in this segment. Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.

229 drugs · Withdrawn · by data quality · Page 6 of 10

  1. desirudin

    REVASC

    EMA: withdrawn

    B01AE01
  2. dexamethasone phosphate

    DEXAMETHASONE TAW

    EMA: application withdrawn

    H02AB02
  3. diclofenamide

    EKESIVY

    EMA: application withdrawn

    S01EC02
  4. diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)

    PRIMAVAX

    EMA: withdrawn

    J07CA
  5. diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)

    TRIACELLUVAX

    EMA: withdrawn

    J07AJ
  6. diphtheria, tetanus, acellular pertussis and hepatitis b recombinant, adsorbed vaccine

    INFANRIX HEPB

    EMA: withdrawn

    J07CA
  7. diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis b (recombinant) and haemophilus influenzae type b conjugate vaccine, adjuvanted

    HEXAVAC

    EMA: withdrawn

    J07CA
  8. diphtheria, tetanus, pertussis (whole cell), hepatitis b (rdna) and haemophilus influenzae type b conjugate vaccine (absorbed)

    QUINTANRIX

    EMA: withdrawn

    J07CA10
  9. dodecafluoropentane

    ECHOGEN

    EMA: withdrawn

    V08DA
  10. drotrecogin alfa (activated)

    XIGRIS

    EMA: withdrawn

    B01AD10
  11. dry aqueous extract of paullinia cupana seed

    CINAINU

    EMA: application withdrawn

  12. ebola vaccine (ad26.zebov-gp [recombinant])

    ZABDENO

    EMA: withdrawn

    J07
  13. ebola vaccine (mva-bn-filo [recombinant])

    MVABEA

    EMA: withdrawn

    J07BX
  14. efalizumab

    RAPTIVA

    EMA: withdrawn

    L04AA21
  15. elivaldogene autotemcel

    SKYSONA

    EMA: withdrawn

    N07
  16. entolimod

    ENTOLIMOD TMC

    EMA: application withdrawn

    L03A
  17. epoetin delta

    DYNEPO

    EMA: withdrawn

    B03XA
  18. eprodisate disodium

    KIACTA

    EMA: application withdrawn

  19. eptotermin alfa

    OSIGRAFT

    EMA: withdrawn

    M05BC02
  20. etarfolatide

    FOLCEPRI

    EMA: application withdrawn

    V09
  21. faldaprevir

    FALDAPREVIR BOEHRINGER INGELHEIM

    EMA: application withdrawn

    J05AE
  22. fidanacogene elaparvovec

    BEQVEZ (PREVIOUSLY DURVEQTIX)

    EMA: withdrawn

  23. fomivirsen

    VITRAVENE

    EMA: withdrawn

    S01AD08
  24. formoterol (fumarate)

    ZENHALE

    EMA: application withdrawn

    R03AK07

Frequently asked questions

How many withdrawn drugs are listed?

229 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.